Literature DB >> 22836923

“Pattern of venous collateral development after splenic vein occlusion in an extended whipple procedure”.

Safi Dokmak.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22836923     DOI： 10.1007/s11605-012-1976-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  5 in total

Review 1.  Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review.

Authors:  Terence C Chua; Akshat Saxena
Journal:  J Gastrointest Surg       Date:  2010-04-09       Impact factor: 3.452

2.  Pattern of venous collateral development after splenic vein occlusion in an extended Whipple procedure : comparison with collateral vein pattern in cases of sinistral portal hypertension.

Authors:  Steven M Strasberg; Sanjeev Bhalla; Luis A Sanchez; David C Linehan
Journal:  J Gastrointest Surg       Date:  2011-09-13       Impact factor: 3.452

3.  Splenic vein-inferior mesenteric vein anastomosis to lessen left-sided portal hypertension after pancreaticoduodenectomy with concomitant vascular resection.

Authors:  Nélio Ferreira; Elie Oussoultzoglou; Pascal Fuchshuber; Dimitrios Ntourakis; Masato Narita; Mudassir Rather; Edoardo Rosso; Pietro Addeo; Patrick Pessaux; Daniel Jaeck; Philippe Bachellier
Journal:  Arch Surg       Date:  2011-12

4.  The role of splenomesenteric vein anastomosis after division of the splenic vein in pancreatoduodenectomy.

Authors:  Koichiro Misuta; Hiroshi Shimada; Yasuhiko Miura; Osamu Kunihiro; Toru Kubota; Itaru Endo; Hitoshi Sekido; Shinji Togo
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

5.  Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.

Authors:  G M Fuhrman; S D Leach; C A Staley; J C Cusack; C Charnsangavej; K R Cleary; A K El-Naggar; C J Fenoglio; J E Lee; D B Evans
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.